Chris Froome: 'Questions remain over Bradley Wiggins steroid use'

Bradley Wiggins and Chris Froome on the podium at the end of the 2012 Tour de France cycling race on July 22, 2012
© Getty Images
Chris Froome says that "questions remain" over Sir Bradley Wiggins's use of steroids ahead of major races, which he claims is a "great shame for the sport".

Three-time Tour de France champion Chris Froome has admitted that "it is impossible to say" if Sir Bradley Wiggins's use of a banned steroid before major races was operating in a grey area.

Wiggins applied for therapeutic use exemptions (TUEs) to take anti-inflammatory drug triamcinolone to help with his allergy and respiratory issues.

The 36-year-old is adamant that he gained no unfair advantage from the drug, which he says simply put him on a "level playing field" with others, but Froome admits that it is a difficult situation and questions will therefore continue to be asked.

"It's impossible to say if he was operating in a grey area," he told Cycling News. "I knew he had asthma, but I wasn't aware of his allergies.

"Questions remain over his symptoms, the choice of treatment and the related performance benefits from that treatment. It's a great shame for the sport that we're once again debating the validity of a Tour de France victory."

Wiggins, Great Britain's most decorated Olympian, took triamcinolone ahead of the 2011 and 2012 Tours and also before the 2013 Giro d'Italia.

Chris Froome of Great Britain and Team Sky chases back to the peloton after being involved in a crash just afte the start of stage four of the 2014 Le Tour de France on July 8, 2014
Read Next:
Froome: 'TUE system open to abuse'